Rigel Assumes Development Responsibility
Pfizer to Sell Capsugel to KKR
http://www.pfizer.com/news/press_releases/pfizer_press_releases.jsp#guid=20110404005842en&source=RSS_2011&page=9
April 29, 2011 - Critical Path Institute Announces Expansion of Regulatory Science Consortium
For Tuberculosis
http://c-path.org/News/CPTRexpansionPR.pdf
ORIGINALLY PROVIDED IMAGE PDF. It would be great if we could get text for this release and create a pdf with it so that it becomes searchable by Search Engines.
April 6, 2011, Nuron Biotech Inc.acquired assets relating to HibTITER®
http://www.nuronbiotech.com/wp-content/uploads/2011/09/hib_Press.pdf
ORIGINALLY PROVIDED IMAGE PDF. It would be great if we could get text for this release
and create a pdf with it so that it becomes searchable by Search Engines.
April 20, 2011 — Pfizer and Shanghai Pharmaceutical Sign Memorandum of Understanding for Potential Strategic Partnership
http://www.pfizer.com/news/press_releases/pfizer_press_releases.jsp#guid=20110420006362en&source=RSS_2011&page=9
April 7, 2011 - Zacharon Announces Collaboration with Pfizer to Develop Drugs for Multiple Rare Diseases.
http://www.zacharon.com/pages/news/downloads/ZacharonPfizerPressReleas4711.pdf
June 02, 2011 — Pfizer and Hisun Sign MOU to Increase Access to Quality and Low-Cost Medicines for Patients in China
http://www.pfizer.com/news/press_releases/pfizer_press_releases.jsp#guid=20110602005965en&source
=RSS_2011&page=6
June 2, 2011 - Clovis Oncology, Inc. Receives License for Worldwide Development and Commercialization Rights to Pfizer’s Oral and IV PARP Inhibitor PF-01367338
http://www.clovisoncology.com/pdf/Pfizer_Clovis_Press_Release_6-2-11.pdf
May 10, 2011 – Cellzome announced joint project with Pfizer’s Pain & Sensory Disorders and egenerative Medicine unit ‘Neusentis’,
http://www.cellzome.com/files/1105_neusentis.pdf
May 9, 2011 – Inhibitex, Inc. Staphylococcus aureus Investigational Vaccine Elicits a Positive Immune Response in Phase 1 Study
http://markets.financialcontent.com/ir/?Module=MediaViewer&GUID=18394647&Ticker=INHX
May 6, 2011 - Rigel Pharmaceuticals, Inc. Rigel Assumes Development Responsibility for!Inhaled Asthma! Therapy
http://ir.rigel.com/phoenix.zhtml?c=120936&p=irol-newsArticle&ID=1560748&highlight=
May 10, 2011 - Foundation for the National Institutes of Health launches trial to develop diabetes Diagnostic tools
http://www.biomarkersconsortium.org/press_release_diabetes_diagnostic_tools.php
June 9, 2011 Q Lpath Granted Two Additional U.S. Patents Related to iSONEP and ASONEP Drug Programs
http://phx.corporate-ir.net/phoenix.zhtml?c=197881&p=irol-newsArticle&ID=1572529&highlight=
The following PR (10/10) mentions Pfizer
October 10, 2011 - Lpath Granted Two Additional U.S. Patents Related to iSONEP and ASONEP Drug Programs
http://phx.corporate-ir.net/phoenix.zhtml?c=197881&p=irol-newsArticle&ID=1613922&highlight=
June 14, 2011 – pSivida and Pfizer Amend Agreement to Focus Solely on Development of SustainedRelease Implant to Deliver Latanoprost for Ocular Hypertension and Glaucoma
http://phx.corporate-ir.net/phoenix.zhtml?c=168274&p=irol-newsArticle&ID=1573632&highlight=
June 14, 2011 - pSivida Announces Phase I/II Clinical Study Evaluating Bioerodible, Sustained Release Latanoprost Device in Ocular Hypertension and Glaucoma
http://phx.corporate-ir.net/phoenix.zhtml?c=168274&p=irol-newsArticle&ID=1573632&highlight=
July 5, 2011 - DNA Electronics' point of care prototype performs well in pilot study with Imperial College and Pfizer http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/newssummary/news_5-7-2011-9-44-25
June 28, 2011 - BioPontis Alliance Enters Translational-Technology Development Agreement with Pfizer
http://www.biopontisalliance.com/news.html
July 5, 2011 - Cell Signaling Technology, Inc. Grants a Patent License to Pfizer
http://www.cellsignal.com/about/press/2011_0605.html
July 07, 2011 — Pfizer To Explore Strategic Alternatives For Its Animal Health And Nutrition Businesses
http://www.pfizer.com/news/press_releases/pfizer_press_releases.jsp#guid=20110707005777en&source=RSS_2011&page=4
August 29, 2011 - Jennewein Biotechnologie and Pfizer Nutrition Collaborate on Human Milk Components
http://www.jennewein-biotech.de/0811_Jennewein_Pfizer_Nutrition_Cooperation.pdf
August 16, 2011 - QIAGEN and Pfizer partner to develop companion diagnostic for novel compound in global clinical trials for lung cancer
http://www.qiagen.com/about/pressreleases/pressreleaseview.aspx?PressReleaseID=358&lang=EN
August 3, 2011 - Biotica regains worldwide rights to its rapamycin analogue program Biotica Technolgoy Ltd.
http://www.biotica.com/index.php/biotica/news_article/biotica_regains_worldwide_rights_to_its_rapamycin_analogue_program/
September 28, 2011 - International Structural Genomics Consortium Announces $48.9 MILLION in Additional Funding to Continue the Search for New Medicines / Consortium also Welcomes Two New Member Companies
http://www.thesgc.org/sites/default/files/SGC_PhaseIII_PR_FINAL_%20for_release_110928_v110926.pdf
September 29, 2011 – Lpath Initiates Dosing of iSONEP in First of Two Proof-of-Concept Trials
http://phx.corporate-ir.net/phoenix.zhtml?c=197881&p=irol-newsArticle&ID=1611349&highlight=
Oct.3,2011– MedImmune, the global biologics arm of AstraZeneca, today announced execution of an inlicensing agreement with Pfizer Inc for tremelimumab (CP-675,206), a CTLA-4 monoclonal antibody.
http://pressroom.medimmune.com/press-releases/2011/10/03/medimmune-in-licenses-cancerimmunotherapy-tremelimumab-from-pfizer/
October 4, Pfizer Oncology/legacy-Serenex
October 05, 2011 — Pfizer Announces Licensing Agreement With Puma Biotechnology, Inc. For The Development And Commercialization Of Neratinib, An Investigational Pan-HER Inhibitor
http://www.pfizer.com/news/press_releases/pfizer_press_releases.jsp#guid=20111005006762en&source=RSS_2011&page=1
March 3,2011 –Charles River Laboratories International, Inc. (NYSE:CRL) today announced that it has entered into a marketing and distribution agreement with Pfizer Inc http://www.criver.com/en-US/NewsEvents/PressReleases/Pages/Pfizer.aspx
October 12,2011 deCODE Announces Agreement with Pfizer to Search!for Variants in the Human Genome that Confer Risk of Systemic Lupus Erythematosis.
http://www.decode.com/news/news.php?story=156
October 10,2011 Exonhit enters into Research Agreement with Pfizer to!identify Alzheimer’s disease biomarkers
http://www.exonhit.com/sites/default/files/PR_Pfizer_EHT_7Q10Q2011_EN.pdf
April 4, 2011 - Oxford BioMedica Broadens 5T4 Antibody Collaboration With Pfizer
http://www.oxfordbiomedica.co.uk/page.asp?pageid=59&newsid=288
October 14 2011 DiaGenic ASA![OSL:DIAG] today reports preliminary positive findings from the collaborative R&D project with Pfizer Inc. where the objective is to identify bloodQbased biomarkers that.
may be useful in diagnosing and monitoring of Alzheimer’s Disease (AD).
http://www.diagenic.com/en/investor_relations/press_releases/Findings+from+DiaGenic%2C+Pfizer+R%26D+Collaboration+Show+Promising+Early+Results+for+Blood-based+Test+f.9UFRrQ2R.ips
